Ledger.Open graph →
SEC Form D · filed January 15, 2025

ImmunoGenesis, Inc

Offering
$25.0M
Sold
$5.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Doylestown, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Ted Koutouzis · Los Angeles, CADirectorRobert B. Stein · Doylestown, PADirectorClifford B. Stocks · Doylestown, PADirectorThomas A. Barton · Doylestown, PADirectorMichael A. Curran · Doylestown, PADirectorJennifer Barlow · Doylestown, PAExec · DirectorMichael A. Curran · Doylestown, PADirectorTed Koutouzis · Los Angeles, CADirectorJennifer Barlow · Doylestown, PAExec · DirectorRobert B. Stein · Doylestown, PADirectorClifford B. Stocks · Doylestown, PADirectorThomas A. Barton · Doylestown, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗